Mason Taylor5 min read
A director at Arcutis Biotherapeutics sold $121,000 in shares under a prearranged plan while ZORYVE revenue surged 65% year over year. Here's what the financials and valuation data reveal about…
Katelyn Marshall5 min read
Alignment Healthcare's EVP sold $550,000 in shares, but a Rule 10b5-1 plan and a blowout Q1 — 33% revenue growth, 88% EBITDA jump — reframe what investors should actually be…
Arnold Tucker4 min read
Salesforce rose 2.3% on a weak tech day after an analyst reaffirmed a $315 target tied to its $3.6 billion Fin acquisition. With shares near a 52-week low and a…
Arnold Tucker6 min read
UPS is spending $48 million on 27 temperature-controlled facilities to chase the booming biologics market. With the stock at $105.83 and a 6.2% yield, we weigh whether the healthcare pivot…
Mason Taylor6 min read
Berkshire Hathaway has committed over $30 billion to Alphabet after Greg Abel's $10 billion block purchase. With GOOGL trading at $346 and an RSI near oversold territory, here's what the…
Tommy Spencer5 min read
Nvidia slid 3.72% to $200.04 as a comparison with newly public SpaceX put its $5.10T valuation back under scrutiny. We weigh the chip leader's growth, P/E and momentum against the…